FIELD: biochemical methods. SUBSTANCE: invention relates to heptapeptide oxytocin analogs of general formula S-Z, wherein S denotes heptapeptide moiety and Z group -NR-CH(Q)-CH2OH,, in which Q is group (CH2)-NH-A n is integer from 1 to 6, A is hydrogen, and R denotes methyl or ethyl group, manifesting activity of oxytocin antagonists. Proposed compounds are characterized by improved stability if aqueous media simultaneously retaining their selectivity and therapeutic efficiency. Method of preparing heptapeptide oxytocin analogs, pharmaceutical composition containing thereof, method of preparing the composition, and method of treating premature birth are also provided. EFFECT: increased choice of biologically active substances. 29 cl, 6 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
OXYTOCIN RECEPTOR AGONISTS | 2010 |
|
RU2539692C2 |
OXYTOCIN ANALOGUES | 2009 |
|
RU2496788C2 |
NOVEL METHODS OF PRODUCING BARUSIBAN AND INTERMEDIATE COMPOUNDS THEREOF | 2016 |
|
RU2726414C2 |
GNRH ANTAGONISTS MODIFIED AT POSITIONS 5 AND 6 | 1998 |
|
RU2199549C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2737264C2 |
STABILIZED COMPOSITION FOR ORAL ADMINISTRATION OF PEPTIDES | 1995 |
|
RU2140790C1 |
PEPTIDE COMPOUNDS | 2007 |
|
RU2415149C2 |
PEPTIDE AGONISTS OF VASOPRESSIN RECEPTOR | 2005 |
|
RU2355701C2 |
APPLICATION OF OXYTOCIN ANTAGONISTS IN ASSISTED REPRODUCTION | 2006 |
|
RU2385735C2 |
Authors
Dates
2002-03-20—Published
1997-11-21—Filed